Home
ivps4
2017-06-16T21:39:52+00:00
News Releases
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jun 29, 2021ORCA-2 Designed to Assess the Efficacy and Safety of 3 mg Cytisinicline Three Times Daily Dosing Compared to Placebo in Adult Smokers in the United States
-
Oct 7, 2020Designed to Assess the Efficacy and Safety of 3 mg Cytisinicline Three Times Daily Dosing Compared to Placebo
-
Sep 18, 2020Subjects in the Cytisinicline Arm Were 55% More Likely to Quit Smoking at 6 Months Compared to Subjects Who Received Varenicline
-
Sep 18, 2020Provides Mechanistic Rationale for the Clinical Findings that Cytisinicline (Cytisine) Treatment is Associated with Lower Rates of Nausea and Vomiting compared to Chantix
-
Apr 24, 2019Topline data from ORCA-1 trial expected in the Second Quarter of 2019
-
Apr 2, 2019Topline data from ORCA-1 trial expected in the Second Quarter of 2019
-
Feb 20, 2019Topline data from ORCA-1 trial expected in mid-2019
-
Sep 18, 2018Cytisine Demonstrated Superior Abstinence Rates Compared to Nicotine Replacement Therapy
Stock Info